» Articles » PMID: 33023555

Correlation of Lower 2 h C-peptide and Elevated Evening Cortisol with High Levels of Depression in Type 2 Diabetes Mellitus

Overview
Journal BMC Psychiatry
Publisher Biomed Central
Specialty Psychiatry
Date 2020 Oct 7
PMID 33023555
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A number of studies have explored the association between depression and ghrelin, leptin, and cortisol; further, postprandial C-peptide levels have a therapeutic effect on type 2 diabetes mellitus (T2DM). However, the relationship between C-peptide and depression in patients with diabetes, remains unclear. The aim of this study was to explore the association between depression and ghrelin, leptin, cortisol, and C-peptide in patients with diabetes.

Methods: We enrolled 50 adults without T2DM, 77 non-depressed adults with T2DM (free of Axis-I psychiatric disorders as assessed using the Mental Illness Needs Index (MINI), Patient Health Questionnaire (PHQ-9 score ≤ 4)) and 59 patients with T2DM and depression (PHQ-9 ≥ 7 and positive by the Structured Clinical Interview for DSM-5). The age range of the participants was 45-59 years of age. We compared the above three groups and explored the association between ghrelin, leptin, cortisol, C-peptide, and depression in patients with diabetes. A post-hoc power-analysis was finished.

Results: Compared with the non-depression T2DM group, the depression T2DM group had significantly higher blood glucose fluctuations. Further, compared with the non-depression T2DM and non-diabetic groups, the depression T2DM group had significantly lower levels of post-meal 2-h C-peptide and elevated evening cortisol (p < 0.01). Regression analysis revealed a significant negative correlation between depression severity and 2-h postprandial C-peptide in patients with diabetes (p < 0.01) and a significant positive correlation with midnight cortisol levels (p < 0.01). A post hoc power analysis showed that we had an adequate sample size and met the minimum requirement to attain 80% power. A post hoc power calculation also demonstrated that this study basically achieved power of 80% at 5% alpha level.

Conclusions: Our findings indicate a correlation of low fasting levels of 2-h C-peptide as well as higher midnight cortisol levels with higher depression severity in middle-aged patients with T2DM.

Citing Articles

Effects of cholecalciferol supplementation on depressive symptoms, C-peptide, serotonin, and neurotrophin-3 in type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial.

Putranto R, Setiati S, Nasrun M, Witjaksono F, Immanuel S, Subekti I Narra J. 2025; 4(3):e1342.

PMID: 39816051 PMC: 11731796. DOI: 10.52225/narra.v4i3.1342.


Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression.

Li S, Yang D, Zhou X, Chen L, Liu L, Lin R CNS Neurosci Ther. 2023; 30(4):e14497.

PMID: 37927197 PMC: 11017426. DOI: 10.1111/cns.14497.


The Effectiveness of a Self-Efficacy-Focused Structured Education Program (SSEP) in Improving Metabolic Control and Psychological Outcomes of Type 2 Diabetes Patients: A 12-Month Follow-Up of a Multicenter Randomized Controlled Trial.

Jiang X, Jiang H, Chen Y, Wu X, Yu X, Liu L Diabetes Metab Syndr Obes. 2021; 14:305-313.

PMID: 33519219 PMC: 7837544. DOI: 10.2147/DMSO.S290029.

References
1.
Lustman P, Clouse R . Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications. 2005; 19(2):113-22. DOI: 10.1016/j.jdiacomp.2004.01.002. View

2.
Milaneschi Y, Sutin A, Terracciano A, Canepa M, Gravenstein K, Egan J . The association between leptin and depressive symptoms is modulated by abdominal adiposity. Psychoneuroendocrinology. 2014; 42:1-10. PMC: 4214922. DOI: 10.1016/j.psyneuen.2013.12.015. View

3.
Barim A, Aydin S, Colak R, Dag E, Deniz O, Sahin I . Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment. Clin Biochem. 2009; 42(10-11):1076-81. DOI: 10.1016/j.clinbiochem.2009.02.020. View

4.
Salinero-Fort M, Gomez-Campelo P, San Andres-Rebollo F, Cardenas-Valladolid J, Abanades-Herranz J, Carrillo De Santa Pau E . Prevalence of depression in patients with type 2 diabetes mellitus in Spain (the DIADEMA Study) : results from the MADIABETES cohort. BMJ Open. 2018; 8(9):e020768. PMC: 6157517. DOI: 10.1136/bmjopen-2017-020768. View

5.
Deuschle M, Blum W, Englaro P, Schweiger U, Weber B, Pflaum C . Plasma leptin in depressed patients and healthy controls. Horm Metab Res. 1996; 28(12):714-7. DOI: 10.1055/s-2007-979885. View